Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. [electronic resource]
Producer: 20120126Description: 982-9 p. digitalISSN:- 1557-3117
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antihypertensive Agents -- administration & dosage
- Child
- Child, Preschool
- Dose-Response Relationship, Drug
- Epoprostenol -- administration & dosage
- Familial Primary Pulmonary Hypertension
- Female
- Humans
- Hypertension, Pulmonary -- diagnosis
- Injections, Subcutaneous
- Male
- Middle Aged
- Multivariate Analysis
- Prognosis
- Retrospective Studies
- Survival Rate
- Treatment Outcome
- Vascular Resistance -- physiology
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.